Skip to main content
. 2021 Dec 23;40(3):437–443. doi: 10.1016/j.vaccine.2021.12.012

Fig. 2.

Fig. 2

SARS-CoV-2 anti-RBD antibody log-scale responses for (A) weekly change for 4 weeks, (B) monthly. Change for 12 weeks. SARS-CoV-2 anti-RBD antibodies (C) change according to age groups, (D) regression model, and (E) heatmap for individuals. SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; RBD, receptor-binding domain of viral spike protein.